Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 3, 2013, Pages 636-642

  Shapiro, Lauren Q ^a   Beal, Kathryn ^a   Goenka, Anuj ^a   Karimi, Sasan ^a   Iwamoto, Fabio M ^a   Yamada, Yoshiya ^a   Zhang, Zhigang ^a   Lassman, Andrew B ^a   Abrey, Lauren E ^a   Gutin, Philip H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEST RESPONSE; BEVACIZUMAB; HIGH-GRADE GLIOMAS; KAPLAN-MEIER METHOD; LOCAL FAILURE; OVERALL SURVIVAL; PATTERNS OF FAILURE; PROGRESSION FREE SURVIVAL; RADIATION FIELD; RADIORESISTANCE; RECURRENT TUMORS; REIRRADIATION; SALVAGE TREATMENT; TREATMENT PLANS; TUMOR GRADES; TUMOR PROGRESSIONS;

MAGNETIC RESONANCE IMAGING; RADIOTHERAPY;

TUMORS;

BEVACIZUMAB; ETOPOSIDE; PERIFOSINE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG APPROVAL; DRUG TREATMENT FAILURE; FEMALE; GLIOMA; HUMAN; HYPOFRACTIONATED STEREOTACTIC RADIATION THERAPY; IMAGE ENHANCEMENT; KAPLAN MEIER METHOD; KARNOFSKY PERFORMANCE STATUS; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; TREATMENT PLANNING; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 84873293197     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.05.031     Document Type: Article

References (21)

1. K.R. Hess, K.R. Broglio, and M.L. Bondy Adult glioma incidence trends in the United States, 1977-2000 Cancer 101 2004 2293 2299
2. A.A. Brandes, A. Tosoni, and E. Franceschi Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status J Clin Oncol 27 2009 1275 1279
3. K.A. Carson, S.A. Grossman, and J.D. Fisher Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials J Clin Oncol 25 2007 2601 2606
4. Y.H. Zhou, F. Tan, and K.R. Hess The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival Clin Cancer Res 9 2003 3369 3375
5. T.N. Kreisl, L. Kim, and K. Moore Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clin Oncol 27 2009 740 745
6. P.H. Gutin, F.M. Iwamoto, and K. Beal Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas Int J Radiat Oncol Biol Phys 75 2009 156 163
7. H.S. Friedman, M.D. Prados, and P.Y. Wen Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J Clin Oncol 27 2009 4733 4740
8. K.C. Cuneo, J.J. Vredenburgh, and J.H. Sampson Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas Int J Radiat Oncol Biol Phys 82 2012 2018 2024
9. F.M. Iwamoto, L.E. Abrey, and K. Beal Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma Neurology 73 2009 1200 1206
10. M.C. Chamberlain Radiographic patterns of relapse in glioblastoma J Neurooncol 101 2011 319 323
11. A.D. Norden, G.S. Young, and K. Setayesh Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence Neurology 70 2008 779 787
12. D.R. Macdonald, T.L. Cascino, and S.C. Schold Jr. Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1990 1277 1280
13. J.J. Vredenburgh, A. Desjardins, and J.P. Kirkpatrick Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme Int J Radiat Oncol Biol Phys 82 2012 58 66
14. M.T. Milano, P. Okunieff, and R.S. Donatello Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma Int J Radiat Oncol Biol Phys 78 2010 1147 1155
15. M.W. McDonald, H.K. Shu, and W.J. Curran Jr. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma Int J Radiat Oncol Biol Phys 79 2011 130 136
16. W.B. Pope, Q. Xia, and V.E. Paton Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab Neurology 76 2011 432 437
17. M. Niyazi, U. Ganswindt, and S.B. Schwarz Irradiation and bevacizumab in high-grade glioma retreatment settings Int J Radiat Oncol Biol Phys 82 2012 67 76
18. S.E. Fogh, D.W. Andrews, and J. Glass Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas J Clin Oncol 28 2010 3048 3053
19. S.E. Combs, C. Thilmann, and L. Edler Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution J Clin Oncol 23 2005 8863 8869
20. P.Y. Wen, D.R. Macdonald, and D.A. Reardon Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972
21. S.F. Shepherd, R.W. Laing, and V.P. Cosgrove Hypofractionated stereotactic radiotherapy in the management of recurrent glioma Int J Radiat Oncol Biol Phys 37 1997 393 398